Finance

Beta
Lists
UNCY:NASDAQ
Unicycive Therapeutics Inc
$4.69
-39.09%
(-3.01) 1D
$4.30
-8.32% (-0.39)
After hours
Closed: Jun 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UNCY...
Open
$4.00
High
$4.92
Low
$3.93
Mkt. cap
125.22M
Avg. vol.
1.27M
Volume
19.77M
52-wk high
$8.74
52-wk low
$3.71
EPS
-$2.08
Beta
1.73
Shares outstanding
26.70M
No. of employees
22
Open
$4.00
High
$4.92
Low
$3.93
Mkt. cap
125.22M
Avg. vol.
1.27M
Volume
19.77M
52-wk high
$8.74
52-wk low
$3.71
EPS
-$2.08
Beta
1.73
Shares outstanding
26.70M
No. of employees
22
News stories
From sources across the web
About Unicycive Therapeutics Inc
CEO-
Employees22
Founded2016
Headquarters-
SectorBiotechnology
Websiteunicycive.com
Analyst ratings
Based on 6 analysts giving stock ratings to UNCY in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for UNCY in the last 3 months.
Highest
Current $4.69
$90.00 (+1,818.98%)
Average
$40.33 (+759.91%)
Lowest
$15.00 (+219.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$22.00
+369.1%
06/30/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$15.00
+219.8%
06/30/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
$18.00
+283.8%
06/02/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$90.00
+1,819%
06/01/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$60.00
+1,179.3%
05/13/2026
Vamil Divan
Guggenheim
Buy
Maintained
$37.00
+688.9%
05/12/2026
Unknown Analyst
Westpark Capital
Buy
Initiated
$72.00
+1,435.2%
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.75M
2.96M
2.25M
1.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.21M
4.38M
4.97M
6.83M
Operating expense
6.96M
7.34M
7.22M
8.44M
Total operating expenses
6.96M
7.34M
7.22M
8.44M
Operating income
-6.96M
-7.34M
-7.22M
-8.44M
Other non operating income
374.00K
1.07M
-7.77M
-4.78M
EBT including unusual items
-6.45M
-6.01M
-14.67M
-12.82M
EBT excluding unusual items
-6.45M
-6.01M
-14.67M
-12.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.45M
-6.01M
-14.67M
-12.82M
Net profit margin
-
-
-
-
Earnings per share
-0.52
-0.33
-0.82
-0.54
Interest and investment income
155.00K
279.00K
351.00K
394.00K
Interest expense
-13.00K
-15.00K
-27.00K
-
Net interest expenses
142.00K
264.00K
324.00K
394.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.96M
-7.33M
-7.21M
-8.43M
Gain or loss from assets sale
-
-
-
18.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer